1. Home
  2. AVTX vs LPTH Comparison

AVTX vs LPTH Comparison

Compare AVTX & LPTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AVTX
  • LPTH
  • Stock Information
  • Founded
  • AVTX 2011
  • LPTH 1985
  • Country
  • AVTX United States
  • LPTH United States
  • Employees
  • AVTX N/A
  • LPTH N/A
  • Industry
  • AVTX Biotechnology: Pharmaceutical Preparations
  • LPTH Semiconductors
  • Sector
  • AVTX Health Care
  • LPTH Technology
  • Exchange
  • AVTX Nasdaq
  • LPTH Nasdaq
  • Market Cap
  • AVTX 248.3M
  • LPTH 282.1M
  • IPO Year
  • AVTX 2015
  • LPTH 1996
  • Fundamental
  • Price
  • AVTX $18.62
  • LPTH $6.93
  • Analyst Decision
  • AVTX Strong Buy
  • LPTH Strong Buy
  • Analyst Count
  • AVTX 9
  • LPTH 3
  • Target Price
  • AVTX $30.14
  • LPTH $10.33
  • AVG Volume (30 Days)
  • AVTX 351.6K
  • LPTH 1.4M
  • Earning Date
  • AVTX 11-06-2025
  • LPTH 11-11-2025
  • Dividend Yield
  • AVTX N/A
  • LPTH N/A
  • EPS Growth
  • AVTX N/A
  • LPTH N/A
  • EPS
  • AVTX N/A
  • LPTH N/A
  • Revenue
  • AVTX $192,000.00
  • LPTH $43,860,530.00
  • Revenue This Year
  • AVTX N/A
  • LPTH $62.13
  • Revenue Next Year
  • AVTX N/A
  • LPTH $22.15
  • P/E Ratio
  • AVTX N/A
  • LPTH N/A
  • Revenue Growth
  • AVTX N/A
  • LPTH 36.85
  • 52 Week Low
  • AVTX $3.39
  • LPTH $1.57
  • 52 Week High
  • AVTX $19.41
  • LPTH $10.69
  • Technical
  • Relative Strength Index (RSI)
  • AVTX 64.08
  • LPTH 45.92
  • Support Level
  • AVTX $16.75
  • LPTH $5.83
  • Resistance Level
  • AVTX $19.29
  • LPTH $7.34
  • Average True Range (ATR)
  • AVTX 1.41
  • LPTH 0.79
  • MACD
  • AVTX 0.17
  • LPTH -0.05
  • Stochastic Oscillator
  • AVTX 87.31
  • LPTH 33.44

About AVTX Avalo Therapeutics Inc.

Avalo Therapeutics Inc is a clinical-stage biotechnology company focused on the treatment of immune dysregulation. The company's asset is AVTX-009, an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalo's pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein).

About LPTH LightPath Technologies Inc.

LightPath Technologies Inc manufactures, distributes, and integrates proprietary optical components and assemblies. It develops optical solutions for traditional optics and communications markets. The company's products include precision molded optics and infrared products, serving markets such as distribution, laser, industrial, instrumentation, telecommunications, and defense. Its products are categorized as infrared components, visible components, assemblies and modules, and engineering services. G5 Infrared's revenue mainly comes from infrared components and assemblies.

Share on Social Networks: